Analysing potent biomarkers along phytochemicals for breast cancer therapy: an in silico approach
- PMID: 37726449
- PMCID: PMC10771382
- DOI: 10.1007/s10549-023-07107-7
Analysing potent biomarkers along phytochemicals for breast cancer therapy: an in silico approach
Abstract
Purpose: This research focused on the identification of herbal compounds as potential anti-cancer drugs, especially for breast cancer, that involved the recognition of Notch downstream targets NOTCH proteins (1-4) specifically expressed in breast tumours as biomarkers for prognosis, along with P53 tumour antigens, that were used as comparisons to check the sensitivity of the herbal bio-compounds.
Methods: After investigating phytochemical candidates, we employed an approach for computer-aided drug design and analysis to find strong breast cancer inhibitors. The present study utilized in silico analyses and protein docking techniques to characterize and rank selected bio-compounds for their efficiency in oncogenic inhibition for use in precise carcinomic cell growth control.
Results: Several of the identified phytocompounds found in herbs followed Lipinski's Rule of Five and could be further investigated as potential medicinal molecules. Based on the Vina score obtained after the docking process, the active compound Epigallocatechin gallate in green tea with NOTCH (1-4) and P53 proteins showed promising results for future drug repurposing. The stiffness and binding stability of green tea pharmacological complexes were further elucidated by the molecular dynamic simulations carried out for the highest scoring phytochemical ligand complex.
Conclusion: The target-ligand complex of green tea active compound Epigallocatechin gallate with NOTCH (1-4) had the potential to become potent anti-breast cancer therapeutic candidates following further research involving wet-lab experiments.
Keywords: Cancer cells; Docking; Herbal compounds; In silico analysis; Phytochemicals.
© 2023. The Author(s).
Conflict of interest statement
The authors have no relevant financial or non-financial interests to disclose.
Figures







Similar articles
-
Chemical Characterization, In-silico Evaluation, and Molecular Docking Analysis of Antiproliferative Compounds Isolated from the Bark of Anthocephalus cadamba Miq.Anticancer Agents Med Chem. 2022;22(20):3416-3437. doi: 10.2174/1871520622666220204123348. Anticancer Agents Med Chem. 2022. PMID: 35125087
-
Pharmacoinformatics approach for the screening of Kovidra (Bauhinia variegata) phytoconstituents against tumor suppressor protein in triple negative breast cancer.J Biomol Struct Dyn. 2024 May;42(8):4263-4282. doi: 10.1080/07391102.2023.2219744. Epub 2023 Jun 8. J Biomol Struct Dyn. 2024. PMID: 37288734
-
Evaluation of tea (Camellia sinensis L.) phytochemicals as multi-disease modulators, a multidimensional in silico strategy with the combinations of network pharmacology, pharmacophore analysis, statistics and molecular docking.Mol Divers. 2023 Feb;27(1):487-509. doi: 10.1007/s11030-022-10437-1. Epub 2022 May 10. Mol Divers. 2023. PMID: 35536529 Free PMC article.
-
In Vitro and In Silico Studies of the Molecular Interactions of Epigallocatechin-3-O-gallate (EGCG) with Proteins That Explain the Health Benefits of Green Tea.Molecules. 2018 May 28;23(6):1295. doi: 10.3390/molecules23061295. Molecules. 2018. PMID: 29843451 Free PMC article. Review.
-
Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy.Semin Cancer Biol. 2016 Oct;40-41:192-208. doi: 10.1016/j.semcancer.2016.09.001. Epub 2016 Sep 5. Semin Cancer Biol. 2016. PMID: 27609747 Free PMC article. Review.
Cited by
-
An in silico molecular docking and simulation study to identify potential anticancer phytochemicals targeting the RAS signaling pathway.PLoS One. 2024 Sep 19;19(9):e0310637. doi: 10.1371/journal.pone.0310637. eCollection 2024. PLoS One. 2024. PMID: 39298437 Free PMC article.
-
Computational identification of potential natural terpenoid inhibitors of MDM2 for breast cancer therapy: molecular docking, molecular dynamics simulation, and ADMET analysis.Front Chem. 2025 Apr 16;13:1527008. doi: 10.3389/fchem.2025.1527008. eCollection 2025. Front Chem. 2025. PMID: 40308267 Free PMC article.
References
-
- ‘Breast cancer’. https://www.who.int/news-room/fact-sheets/detail/breast-cancer . Accessed 25 May 2023
-
- ‘Breast cancer|Elsevier Enhanced Reader’. https://reader.elsevier.com/reader/sd/pii/S0140673620323813?token=F04EE0.... Accessed 23 Mar 2023
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous